POZEN, Inc. (NASDAQ:POZN)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.

Recs

0
Player Avatar drobuck340 (< 20) Submitted: 4/29/2010 12:16:04 AM : Outperform Start Price: $11.00 POZN Score: -46.90

great stock

Featured Broker Partners


Advertisement